James Hardie Industries heads into its August 6 earnings release with options positioning noticeably more defensive than it has been for most of the past year.
The clearest shift is in the put/call ratio. It climbed to 0.36 at the end of July, nearly a full standard deviation above its 20-day average of 0.30 — a move that looks more significant in context: the PCR sat closer to 0.24 through most of June and early July before stepping up sharply around July 20. That's a meaningful reorientation toward downside protection in the weeks immediately preceding the print. Borrow conditions, by contrast, offer no corroboration. Availability remains extremely loose at nearly 964% — roughly ten shares available to borrow for every one already lent out — and cost to borrow holds at a negligible 0.57%. Shorts have nudged higher over the past week, up around 3.6% in shares, but the absolute level is modest and the lending market shows no sign of stress.
The bull and bear debate centers on timing and trajectory rather than the business itself. On the bullish side, forward earnings momentum is genuinely strong: the 12-month forward EPS growth rank sits in the 85th percentile of the universe, and the stock's sector score ranks in the top 10%. A director purchase at $22.91 in early June, made when the stock was trading well below current levels, adds a modest insider conviction signal. Bears, meanwhile, can point to the EPS surprise rank languishing in just the 16th percentile — the company has a recent habit of missing estimates — and the stock's price-to-book has compressed sharply over the past month, falling by nearly 1.9x in 30 days. The PE sits at roughly 18.6x, down modestly on the week but up about 1.3 points over the month, as the stock's flat-to-positive one-month performance (+0.4%) has done little to resolve valuation ambiguity. The ORTEX short score, at 37.7, is benign and has been largely range-bound over the past two weeks.
Institutional ownership provides useful colour on who is watching most closely. Wellington Management holds a dominant 16% of shares, with FMR (Fidelity) recently adding 3.5 million shares to lift its stake to 6%. D1 Capital Partners also added in the most recent reporting period, taking its position above 5%. These are active, high-conviction managers — concentrated ownership of this kind tends to amplify post-earnings moves in either direction. The most recent prior earnings event, in May 2026, saw the stock gain nearly 4% on the day and extend to an 8.4% gain over the following five days. The event before that, in late April 2026, produced an 8.4% single-day decline.
Thursday's print tests whether the forward EPS recovery narrative — which has driven meaningful institutional accumulation — can survive contact with a company that has recently struggled to beat its own numbers.
See the live data behind this article on ORTEX.
Open JHX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
